TTTS typically presents during pregnancy, often between 16 and 26 weeks of gestation. The condition is usually detected through routine ultrasound examinations. Key signs include a significant difference in the amniotic fluid levels surrounding each twin, with the recipient twin having too much fluid (polyhydramnios) and the donor twin having too little (oligohydramnios). The recipient twin may also show signs of heart strain due to the excess blood volume, while the donor twin may appear smaller and have reduced growth.

The diagnosis of TTTS is primarily made through ultrasound imaging. During the ultrasound, doctors look for the "stuck twin" phenomenon, where the donor twin appears to be stuck to the uterine wall due to low amniotic fluid. Doppler studies, which assess blood flow in the umbilical cords and fetal vessels, can provide additional information about the severity of the condition. In some cases, fetal echocardiography may be performed to evaluate the heart function of the recipient twin.

The treatment of TTTS depends on the severity of the condition and the gestational age of the pregnancy. Options include:

• Amnioreduction: This involves removing excess amniotic fluid from around the recipient twin to relieve pressure and improve blood flow.
• Laser Therapy: A more definitive treatment, laser therapy involves using a laser to seal off the abnormal blood vessels on the placenta that are causing the imbalance.
• Selective Reduction: In severe cases, reducing the number of fetuses may be considered to improve the chances of survival for the remaining twin(s).
• Early Delivery: If the pregnancy is far enough along, early delivery may be the best option to prevent further complications.

The prognosis for TTTS varies depending on the severity of the condition and the timing of intervention. Without treatment, the condition can lead to serious complications, including heart failure in the recipient twin and growth restriction in the donor twin. With appropriate treatment, the survival rate for at least one twin can be significantly improved, although there may still be risks of neurological and developmental issues.

TTTS is caused by abnormal blood vessel connections in the shared placenta of identical twins. These connections allow blood to flow unevenly between the twins, leading to the characteristic symptoms of the syndrome. The exact cause of these abnormal connections is not well understood, but they are a result of the shared placental structure in monochorionic pregnancies (where twins share a single placenta).

TTTS occurs in approximately 10-15% of monochorionic twin pregnancies. It is a condition unique to identical twins who share a placenta, and it does not occur in fraternal twins, who have separate placentas. The risk of TTTS is not influenced by maternal age, race, or other demographic factors.

In TTTS, the shared placenta contains abnormal blood vessel connections that allow blood to flow disproportionately between the twins. The donor twin, which gives away more blood than it receives, becomes anemic and may experience growth restriction. The recipient twin, receiving excess blood, can develop polycythemia (increased red blood cells) and heart problems due to the increased blood volume. This imbalance can lead to serious complications for both twins if not addressed.

Currently, there is no known way to prevent TTTS, as it is related to the natural development of the placenta in monochorionic pregnancies. However, early and regular prenatal care, including frequent ultrasounds, can help detect the condition early and allow for timely intervention. Pregnant women with monochorionic twins should be monitored closely by a specialist familiar with TTTS.

Twin-to-Twin Transfusion Syndrome is a serious condition affecting identical twins sharing a placenta. It results from abnormal blood vessel connections that cause an imbalance in blood flow between the twins. Early detection through ultrasound and appropriate treatment, such as laser therapy or amnioreduction, can improve outcomes. While the condition cannot be prevented, close monitoring during pregnancy is crucial for managing TTTS effectively.

If you are expecting identical twins, it's important to be aware of Twin-to-Twin Transfusion Syndrome (TTTS), a condition that can affect twins sharing a placenta. TTTS can lead to one twin receiving too much blood and the other too little, causing health issues for both. Regular ultrasounds and monitoring by your healthcare provider can help detect TTTS early. Treatment options are available and can significantly improve the chances of a healthy outcome for your twins. Always discuss any concerns with your healthcare provider to ensure the best care for you and your babies.